Ipsen

Ipsen expands collaboration and license agreement for development of therapy in advanced pancreatic and extra-pancreatic neuroendocrine tumors. Learn more: ipsen.to/XQLYmxg

🎉🌈 Celebrating Spectra ERG's First Anniversary! 🌈🎉 One year ago, Eric, Sam, Courtney, and Aline came together to launch Spectra ERG at Ipsen, dedicated to supporting our LGBTQIA community. Spectra is a beacon of advocacy, education, and community outreach with a clear mission: to empower colleagues, highlight LGBTQIA experiences, and create an inclusive workplace.  Find out more here about Spectra’s focus on the future here https://ipsen.to/A0A4w9 #Inclusion #Diversity #LGBTQIA #SpectraERG #Pride #Ipsen #GenerationIpsen 

For those living with the rare cholestatic liver disease #PrimaryBiliaryCholangitis (PBC), symptoms are chronic, often unbearable and have a significant negative impact on quality of life. For many, including Sabrina, debilitating fatigue and pruritus (intolerable itching) affect life every day.  Watch Sabrina’s full story here: [link to Ipsen.com] 

Generation Ipsen is both the bedrock and the conduit for our sustainability efforts. Our strategy and goals are set to drive positive action across the globe through four pillars: 🌍 Environment 😷 Patients 🧑People 👩💼Governance Read our 2023 Annual Report to discover how Generation Ipsen is making sustainable growth possible. Learn more: https://lnkd.in/dD5XWWuM

Listening and empowering people to feel confident during conversations with healthcare professionals when planning care can have a positive impact on their mental health and quality of life. Co-creating the first Shared Decision Making Action Plan for kidney cancer meant listening to the experiences of patients, healthcare professionals, patient advocates and carers, to put their insights at the heart of the Action Plans recommendations. Download the plan created with the kidney cancer community, for the kidney cancer community, here: https://bit.ly/3UYISwg #WorldKidneyCancerDay2024 #TogetherForKidneyCancer #ShareDecisionMaking

In #PrimaryBiliaryCholangitis (PBC), the body attacks and destroys the liver's small bile ducts, potentially leading to liver failure.     At last week’s #EASLCongress, liver experts emphasized the importance of proactive, personalized care and shared decision-making during consultations.    Hear from Wendy who lives with PBC on the importance of being involved in the patient care plan, and understanding disease progression and how this is measured: https://lnkd.in/eZfy2--D   #PatientCare #CholestaticLiverDisease 

For people living with primary biliary cholangitis (PBC), the symptoms they experience can have a debilitating impact on everyday life. Carol, who is an advocate for PBC, shares her perspective on unmet needs and progress for the community. Read more: https://bit.ly/3RleBqk

Exciting News! An advancement in the treatment of Primary Biliary Cholangitis (PBC) has just received US regulatory accelerated approval. A cause for celebration for people living with this rare and challenging liver condition.

We are delighted to share that the U.S. FDA, has granted accelerated approval for our new, first -in-class treatment for the rare cholestatic liver disease, primary biliary cholangitis (PBC).

Ipsen and Marengo announce second strategic partnership in oncology.